GLP-1 medications are FDA-approved for two distinct indications: type 2 diabetes (Ozempic, Mounjaro) and chronic weight management (Wegovy, Zepbound). The same active ingredients serve both purposes, but the clinical approach differs.
The Key Differences
| Dimension | For Type 2 Diabetes | For Weight Loss |
|---|---|---|
| Primary goal | Blood sugar control (A1C reduction) | Body weight reduction |
| Target dose | Often lower (0.5-1.0mg semaglutide) | Maximum tolerated (2.4mg semaglutide) |
| BMI requirement | None (diabetes is the indication) | ≥30, or ≥27 with comorbidity |
| Insurance coverage | Better — diabetes is covered broadly | Variable — many plans exclude obesity |
| A1C monitoring | Every 3 months | Not required (unless diabetic) |
| Hypoglycemia risk | Higher (especially with insulin) | Low |
| Duration of treatment | Indefinite (chronic disease) | Indefinite (chronic condition) |
The Insurance Gap
Here's the practical reality: if you have type 2 diabetes, your insurance is far more likely to cover GLP-1 medication than if your only diagnosis is obesity. This creates an access disparity that compounded medications partially address — self-pay patients without diabetes-related coverage can access the same active ingredients at lower cost through telehealth providers.
Dual-Benefit Patients
Many patients have both conditions — approximately 90% of type 2 diabetics are overweight or obese. For these patients, GLP-1 medication addresses both simultaneously. The medication improves A1C while reducing body weight, and the weight loss itself improves insulin sensitivity, creating a virtuous cycle.
The Medicare Factor
Starting July 1, 2026, the Medicare GLP-1 Bridge provides eligible Part D beneficiaries access to GLP-1 medications for $50/month. This covers both diabetes and weight-loss indications, though the specific formulary will determine which drugs are available. For Medicare patients, this represents the most affordable pathway to brand-name GLP-1 treatment.
Sunlight $159/mo sema, $239/mo tirz · LegitScript certified. Flat pricing — $159 first month, $179 ongoing (semaglutide). No membership, free shipping, HSA/FSA.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.
Sesame Care From $99/visit · Prescribes FDA-approved brand-name medications only. Accepts insurance. No subscription lock-in.
Prescribes FDA-approved brand-name medications only.
⚕️ Compounded medications are not FDA-approved. They are prepared by licensed pharmacies under physician supervision.